Doxorubicin is a cytotoxic anthracycline antibiotic isolated from cultures of Streptomyces peucetius var. caesius along side with daunorubicin, another cytotoxic agent, in 1970. Although they both have aglyconic and sugar moieties, doxorubicin's side chain terminates with a primary alcohol group compared to the methyl group of daunorubicin. Although its deta...
Doxorubicin is indicated for the treatment of neoplastic conditions like acute lymphoblastic leukemia, acute myeloblastic leukemia, Hodgkin and non-Hodgkin lymphoma, metastatic breast cancer, metastatic Wilms’ tumor, metastatic neuroblastoma, metastatic soft tissue and bone sarcomas, metastatic ovarian carcinoma, metastatic transitional cell bladder carcinom...
Keck Medicine of USC Koreatown, Los Angeles, California, United States
Los Angeles General Medical Center, Los Angeles, California, United States
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
National Cancer Center/Tumor Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China
University of Miami, Miami, Florida, United States
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
Cancer Care Specialists, Reno, Nevada, United States
Local Institution - 0498, East Brunswick, New Jersey, United States
Moffitt Cancer Center, Tampa, Florida, United States
University Malaya Medical Centre, Kuala Lumpur, Malaysia
Subang Jaya Medical Centre, Kuala Lumpur, Malaysia
KK Women's and Children's Hospital, Singapore, Singapore
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.